Genmab valuation

GMAB · Nasdaq Copenhagen · DKK

Compare Genmab
kr 3,502.00Change from previous close: −0.77%Absolute change: −kr 27.00

Close · November 17, 2026

Valuation

The P/E ratio is 46.2. The average price target of 13 analysts is kr 4,195.23.

Data as of November 17, 2026

Genmab compared with similar companies

Genmab's P/E (trailing 12 months): 46.2, +16% against the median of a group of 10 similar companies (40.0).

Genmab's metrics compared with similar companies
MetricGenmabMedian25th–75th percentileBand
P/E (trailing 12 months)46.240.015.7 – 55.4Middle
Forward P/E29.731.623.9 – 37.2Middle
EV/EBITDA167.227.318.1 – 63.0High
Price/book5.225.222.75 – 8.40Middle
Price/sales49.98.063.49 – 18.2High
Gross margin92.7%76.2%59.2% – 93.2%Middle
Operating margin30.6%26.9%13.3% – 34.0%Middle
Net margin17.0%19.9%12.3% – 28.5%Middle
ROE12.1%12.1%6.0% – 19.6%Middle
Debt/equity0.820.030.02 – 0.10High

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
kr 214.45B
Enterprise value
kr 226.7B
PEG
4.60
EV/revenue
52.8

Profitability and growth

ROA
8.2%
ROIC
12.7%
Revenue growth (year over year)
16.1%
Earnings growth (year over year)
-14.7%

Financial health

Total cash
kr 1.87B
Total debt
kr 5.2B
Current ratio
2.45
Quick ratio
2.43
Altman Z-Score
3.02
Piotroski F-Score
4.00

Dividends

Dividend yield
0.0%
Payout ratio
0.0%

Analysts and estimates

Average price target
kr 4,195.23
Median price target
kr 4,415.00
High price target
kr 4,900.00
Low price target
kr 3,200.00
Analysts with a price target
13
Consensus
Strong buy
Forward EPS
kr 117.07
EPS estimate, current year
kr 84.26

Shares and trading

Beta
0.52
Average volume
157.81K
Shares outstanding
61.66M
Float
58.91M
Institutional ownership
46.4%
Insider ownership
1.1%